Wednesday, January 10, 2024 9:19:45 AM
“Q4 2023 was a record quarter of revenue for SANUWAVE driven by strength in the UltraMist product line. Consumables and in particular system sales saw accelerating growth as production constraints were overcome,” said CEO Morgan Frank. “We’re extremely pleased to have shown this level of growth year on year up against what had previously been the best quarter in SANUWAVE history in Q4 2022 and look forward to carrying this success on into 2024. The Company plans to release its full Q4 and annual results in late March and we look forward to speaking with you then to give you a more complete update on our quarterly and yearly performance and our future plans and guidance.”
The preliminary revenue results described herein are based on management’s initial analysis of the fourth quarter ended December 31, 2023, and may be subject to adjustments based on the Company’s completion of its year-end financial close process.
Recent SNWV News
- Form 425 - Prospectuses and communications, business combinations • Edgar (US Regulatory) • 02/28/2024 10:03:27 PM
- Form 425 - Prospectuses and communications, business combinations • Edgar (US Regulatory) • 02/21/2024 09:07:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/21/2024 09:05:50 PM
- Form D - Notice of Exempt Offering of Securities • Edgar (US Regulatory) • 02/05/2024 11:09:04 AM
- Form 425 - Prospectuses and communications, business combinations • Edgar (US Regulatory) • 01/25/2024 10:17:44 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/25/2024 09:46:34 PM
- Form 425 - Prospectuses and communications, business combinations • Edgar (US Regulatory) • 01/22/2024 09:45:55 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/10/2024 09:05:36 PM
- Form 425 - Prospectuses and communications, business combinations • Edgar (US Regulatory) • 01/03/2024 10:21:49 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/03/2024 10:17:17 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/13/2023 10:13:30 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/09/2023 09:41:10 PM
- Form 425 - Prospectuses and communications, business combinations • Edgar (US Regulatory) • 10/12/2023 08:32:48 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/10/2023 11:35:26 AM
- Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend] • Edgar (US Regulatory) • 09/29/2023 10:03:14 AM
- Form 425 - Prospectuses and communications, business combinations • Edgar (US Regulatory) • 09/25/2023 08:19:02 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/25/2023 08:15:36 PM
- Form 425 - Prospectuses and communications, business combinations • Edgar (US Regulatory) • 08/24/2023 08:08:24 PM
- Form 425 - Prospectuses and communications, business combinations • Edgar (US Regulatory) • 08/23/2023 09:05:06 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/23/2023 08:51:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/11/2023 08:47:24 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/10/2023 08:11:04 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 08/08/2023 01:38:36 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM